Prostatis Group’s iShares MSCI France ETF EWQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Buy
112,514
+31,225
+38% +$1.42M 1.19% 19
2026
Q1
$3.53M Sell
81,289
-7,891
-9% -$357K 0.9% 36
2025
Q4
$4.01M Buy
89,180
+9,150
+11% +$407K 0.96% 32
2025
Q3
$3.52M Buy
80,030
+8,110
+11% +$350K 0.88% 34
2025
Q2
$3.08M Buy
+71,920
New +$2.97M 0.88% 33
2023
Q3
Sell
-58,091
Closed -$2.24M 139
2023
Q2
$2.24M Buy
58,091
+7,972
+16% +$306K 1.04% 22
2023
Q1
$1.95M Buy
+50,119
New +$1.83M 1.03% 27

Other funds holding EWQ

Prostatis Group's EWQ Position: Q2 2026 in Review

Prostatis Group increased its iShares MSCI France ETF (EWQ) stake by 38% in Q2 2026, buying an estimated $1.42M and bringing the position to 112,514 shares worth $5.11M. The position accounts for 1.19% of the portfolio, ranked #19.

Prostatis Group first reported a position in EWQ in Q1 2023 and has held it in 7 quarters since. 90 funds tracked by Wall St. Rank hold EWQ as of Q2 2026.

  • Prostatis Group held 112,514 shares of iShares MSCI France ETF worth $5.11M as of Q2 2026.
  • Prostatis Group bought 31,225 iShares MSCI France ETF shares in Q2 2026, an estimated $1.42M.
  • iShares MSCI France ETF made up 1.19% of Prostatis Group's portfolio in Q2 2026, its #19 holding.
  • Prostatis Group first reported a position in iShares MSCI France ETF in Q1 2023 and has held it in 7 quarters since.
  • 90 funds tracked by Wall St. Rank held iShares MSCI France ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.